Form 4 for PFE Pfizer
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-27 · accession 0001225208-24-003197 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-28 | 2024-02-27 | PFE | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +5,113 | 13.5K | +61% | $0 |
| DM | 2024-02-28 | 2024-02-27 | PFE | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +37.1K | 17.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | A | A | 5,113 | $0.00 | 13,495 | D | — | — | (F1) The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. |
| 2 | Derivative | Stock Appreciation Rights | 2024-02-27 | A | A | 19,697 | $0.00 | 19,697 | D | $26.89 · 2029-02-27 to 2029-02-27 | 19,697 Common Stock | (F2) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
| 3 | Derivative | Stock Appreciation Rights | 2024-02-27 | A | A | 17,404 | $0.00 | 17,404 | D | $26.89 · 2031-02-27 to 2031-02-27 | 17,404 Common Stock | (F3) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |